The Role of C-Reactive Protein as a Risk Predictor of Coronary Atherosclerosis: Implications from the JUPITER Trial
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of C-Reactive Protein as a Risk Predictor of Coronary Atherosclerosis: Implications from the JUPITER Trial
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume 13, Issue 2, Pages 154-161
Publisher
Springer Nature
Online
2011-01-29
DOI
10.1007/s11883-011-0164-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessing the Value of Risk Predictions by Using Risk Stratification Tables
- (2013) Holly Janes et al. ANNALS OF INTERNAL MEDICINE
- Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
- (2013) Mark J. Pletcher ANNALS OF INTERNAL MEDICINE
- C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
- (2013) David I. Buckley et al. ANNALS OF INTERNAL MEDICINE
- Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease
- (2013) Rodney A. Hayward ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy
- (2010) Keane K. Lee et al. CIRCULATION
- Should We Measure C-reactive Protein on Earth or Just on JUPITER?
- (2010) Ambareesh Bajpai et al. CLINICAL CARDIOLOGY
- Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER
- (2010) Julia F. Slejko et al. CURRENT MEDICAL RESEARCH AND OPINION
- Another Look at the Results of the JUPITER Trial
- (2009) C. Tissa Kappagoda et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
- (2009) John J.V. McMurray et al. CIRCULATION
- Criteria for Evaluation of Novel Markers of Cardiovascular Risk
- (2009) Mark A. Hlatky et al. CIRCULATION
- From Here to JUPITER
- (2009) Erica S. Spatz et al.
- Rosuvastatin in Patients with Elevated C-Reactive Protein
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Lipids, atherosclerosis and CVD risk: Is CRP an innocent bystander?
- (2009) B.G. Nordestgaard et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
- (2008) Peter W.F. Wilson et al.
- Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts
- (2008) Tina Shah et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- C-reactive protein and coronary heart disease: a critical review
- (2008) J. P. Casas et al. JOURNAL OF INTERNAL MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
- (2008) Jeppe Zacho et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started